These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21063489)

  • 41. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
    Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
    Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation.
    Desta YT; Wu M; Bai L; Wu X; Xiong M; Weng X
    Int Immunopharmacol; 2020 Jul; 84():106518. PubMed ID: 32380408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.
    Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M
    J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis.
    Louis H; Le Moine A; Quertinmont E; Peny MO; Geerts A; Goldman M; Le Moine O; Devière J
    Hepatology; 2000 Feb; 31(2):381-90. PubMed ID: 10655261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
    Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
    Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.
    Ajuebor MN; Hogaboam CM; Le T; Swain MG
    J Immunol; 2003 May; 170(10):5252-9. PubMed ID: 12734374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender-related differences in concanavalin A-induced liver injury and cytokine production in mice.
    Takamoto S; Nakamura K; Yoneda M; Makino I
    Hepatol Res; 2003 Nov; 27(3):221-229. PubMed ID: 14585399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
    Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
    Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression.
    Tu CT; Han B; Yao QY; Zhang YA; Liu HC; Zhang SC
    Int Immunopharmacol; 2012 Jan; 12(1):151-7. PubMed ID: 22138522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) reduces hepatic injury in concanavalin A-treated mice.
    Ko YE; Yoon SY; Ly SY; Kim JH; Sohn KY; Kim JW
    J Cell Biochem; 2018 Feb; 119(2):1392-1405. PubMed ID: 28749086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
    Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
    Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etanercept attenuates immune-mediated hepatitis induced by concanavalin A via differential regulation of the key effector cytokines of CD4+ T cells.
    Elshal M; Abu-Elsaad N; El-Karef A; Ibrahim T
    Life Sci; 2021 Jul; 277():119618. PubMed ID: 34004252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
    Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
    Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
    J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
    Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
    J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resveratrol Pretreatment Attenuates Concanavalin A-induced Hepatitis through Reverse of Aberration in the Immune Response and Regenerative Capacity in Aged Mice.
    Huang TH; Chen CC; Liu HM; Lee TY; Shieh SH
    Sci Rep; 2017 Jun; 7(1):2705. PubMed ID: 28578410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
    Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species.
    Mounieb F; Ramadan L; Akool ES; Balah A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1105-1115. PubMed ID: 28761978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.